Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-25-000039
Filing Date
2025-02-12
Accepted
2025-02-12 16:36:29
Documents
1
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739396180.html 4  
1 FORM 4 wk-form4_1739396180.xml 4 5135
  Complete submission text file 0000875320-25-000039.txt   6553
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Biller Jonathan (Reporting) CIK: 0001744749 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 25615412